Search

everythinglearnresearchcommunity

for

Search:↓

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

Applying a specific inhibitor lightens skin and hair color.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Finasteride is mainly broken down by the enzyme CYP3A4, affecting its levels in the body.

Cadd4 effectively reduces cholesterol levels without side effects.

Cyclosporine A slowly changes cell membranes, explaining some of its effects and side effects.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Compound 7p shows strong potential as an anticancer agent.